Teva Active Pharmaceutical Ingredients

Teva Active Pharmaceutical Ingredients (TAPI) is a division of Teva Pharmaceuticals, one of the largest pharmaceutical companies in the world. TAPI specializes in the development, production, and marketing of Active Pharmaceutical Ingredients (APIs), which are the essential components in the manufacturing of pharmaceutical drugs. The division plays a crucial role in the global pharmaceutical supply chain, providing APIs for both Teva's proprietary medications and generic drugs, as well as for other pharmaceutical companies.

Overview

Teva Active Pharmaceutical Ingredients operates globally, with manufacturing and research and development (R&D) facilities located in multiple countries, including the United States, Europe, Israel, and India. The division is known for its extensive product portfolio, which encompasses a wide range of therapeutic areas such as cardiovascular, central nervous system (CNS), Oncology, Pain management, and respiratory diseases, among others. TAPI's commitment to quality and compliance with international regulatory standards ensures the safety and efficacy of its products.

History

Teva Active Pharmaceutical Ingredients was established as part of Teva Pharmaceuticals' strategic expansion into the API market. Over the years, TAPI has grown through acquisitions and organic growth, solidifying its position as a leading supplier of APIs worldwide. The division's history is marked by significant investments in R&D, enabling the development of high-quality, complex APIs and the enhancement of its manufacturing capabilities.

Products and Services

TAPI offers a broad range of APIs, including both small molecules and biologics, for various dosage forms such as oral, injectable, and inhalation. The division's product catalog is continuously expanding, driven by its strong focus on R&D and innovation. In addition to APIs, TAPI provides a suite of services, including custom synthesis, process development, and contract manufacturing, catering to the specific needs of its customers.

Research and Development

Research and development are at the core of TAPI's operations. The division invests heavily in R&D to develop new APIs, improve existing processes, and enhance product quality. Its R&D efforts are supported by a team of highly skilled scientists and state-of-the-art laboratories equipped with the latest technology. TAPI's R&D activities also focus on sustainability, aiming to minimize the environmental impact of its manufacturing processes.

Regulatory Compliance

Teva Active Pharmaceutical Ingredients adheres to the highest standards of regulatory compliance. The division's manufacturing facilities are regularly inspected and approved by major regulatory authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO). TAPI's commitment to compliance ensures that its APIs meet the stringent requirements of the pharmaceutical industry, guaranteeing the safety and reliability of the drugs produced using its products.

Global Presence

With a global network of manufacturing and R&D facilities, TAPI serves customers in over 100 countries. The division's international presence allows it to offer localized support and services, ensuring timely delivery of its products to pharmaceutical companies around the world. TAPI's global operations also facilitate access to emerging markets, where the demand for high-quality APIs is rapidly growing.

Conclusion

Teva Active Pharmaceutical Ingredients is a key player in the pharmaceutical industry, providing essential components for drug manufacturing. Through its commitment to quality, innovation, and regulatory compliance, TAPI supports the development and production of effective and safe medications, contributing to global health and well-being.

‎